Jeff Yass’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$210K Buy
+11,246
New +$227K ﹤0.01% 11835
2014
Q4
– Sell
-29,393
Closed -$650K – 9805
2014
Q3
$650K Sell
29,393
-197,326
-87% -$4.29M ﹤0.01% 6725
2014
Q2
$4.71M Buy
+226,719
New +$4.76M ﹤0.01% 3185

Other funds holding HQL

Jeff Yass's HQL Position: Q3 2026 in Review

Jeff Yass opened a new position in abrdn Life Sciences Investors (HQL) in Q3 2026: 11,246 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #11835 among its holdings. This is a return to the name: Jeff Yass previously reported a position in HQL as recently as Q3 2014.

Jeff Yass first reported a position in HQL in Q2 2014 and has held it in 3 quarters since. The position peaked at $4.71M in Q2 2014. 82 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

  • Jeff Yass held 11,246 shares of abrdn Life Sciences Investors worth $210K as of Q3 2026.
  • abrdn Life Sciences Investors was a new Jeff Yass position in Q3 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11835 holding.
  • Jeff Yass first reported a position in abrdn Life Sciences Investors in Q2 2014 and has held it in 3 quarters since.
  • Jeff Yass's abrdn Life Sciences Investors position peaked at $4.71M in Q2 2014.
  • 82 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.